SCHEMBL23201575

SCHEMBL23201575

CC(C)[C@H](NC(=O)O)C(=O)Cl

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
TSHR P16473 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G5 P39877 1/20 0.32
CA12 O43570 1/20 0.31
CA14 Q9ULX7 1/20 0.31
SDCBP O00560 1/20 0.31
SDC2 P34741 1/20 0.31
KDM4E B2RXH2 1/20 0.31
FPR2 P25090 1/20 0.31
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15526954 1.00 SMN1; SMN2 (0.33) SMN1; SMN2ALDH1A1NPSR1CYP2D6CYP2C19
SCHEMBL8752641 0.79 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1NPSR1TSHRLMNA
SCHEMBL9717667 0.79 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1NPSR1TSHRLMNA
SCHEMBL14389451 0.79 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1NPSR1TSHRLMNA
SCHEMBL13049754 0.77 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1NPSR1CYP2D6CYP2C19
SCHEMBL1496401 0.77 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1NPSR1CYP2D6CYP2C19
SCHEMBL13049755 0.77 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1NPSR1CYP2D6CYP2C19
SCHEMBL1440450 0.76 CA12 (0.38) SMN1; SMN2ALDH1A1NPSR1CYP2C19TSHR
SCHEMBL7465674 0.76 LMNA (0.33) SMN1; SMN2ALDH1A1CYP2D6CYP2C19TSHR
SCHEMBL7465668 0.76 LMNA (0.33) SMN1; SMN2ALDH1A1CYP2D6CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3801537-A2 COMPOUNDS AND METHODS FOR MODULATION OF G-PROTEIN-COUPLED RECEPTORS Primetime Life Sciences, LLC (US) 2021-04-14 EP disclosed